공유
))
Get in-depth coverage of current and future trends in technology, and how they are shaping business, entertainment, communications, science, politics, and society.
…
continue reading
Part 2: The Inflazome Story - the research, the deal and scientists that made it happen
Manage episode 307778360 series 3009792
Player FM과 저희 커뮤니티의 MTPConnect 콘텐츠는 모두 원 저작자에게 속하며 Player FM이 아닌 작가가 저작권을 갖습니다. 오디오는 해당 서버에서 직접 스트리밍 됩니다. 구독 버튼을 눌러 Player FM에서 업데이트 현황을 확인하세요. 혹은 다른 팟캐스트 앱에서 URL을 불러오세요.
Tune in for part 2 of our 100th episode special, following our chat with Professor Kate Schroder, head of the Inflammasome Laboratory and Director of the Centre for Inflammation and Disease Research at the Institute for Molecular Bioscience (IMB), University of Queensland and Professor Ian Henderson, the Director of IMB. We explore the story behind the milestone research discovery that could lead to a treatment for conditions like Parkinson’s and Alzheimer’s disease, Motor Neurone Disease – even asthma. The innovation was developed out of the UQ, in partnership with Trinity College in Dublin. And the start-up company spawned by the research – Inflazome - was recently acquired by Roche in a deal worth around $600 million, making it one of Australia’s largest ever biotech deals. We also explore the broader work of IMB and the international collaborative approach underpinning its research successes.
153 에피소드
